期刊文献+

纯化花粉变应原免疫治疗的疗效观察 被引量:2

Effect of immunotherapy with purified pollen allergens
暂未订购
导出
摘要 目的:观察纯化花粉(黄蒿、葎草、藜草花粉)变应原特异性免疫治疗(SIT)的疗效.方法:采取凝胶过滤方法分别提纯上述花粉变应原.采取随机、对照方法将102例确诊为季节性黄蒿、葎草、藜草花粉过敏性哮喘患者分为观察组(A组)及对照组(B组),应用纯化花粉变应原(PPA)及粗花粉变应原(CPA)分别对两组患者进行季节前SIT,疗程3mo.临床疗效判断标准为显效、好转及无效.临床不良反应观察包括局部或全身皮疹、哮喘加重等.实验观察指标为两组SIT前后的皮肤试验(ID)风团直径、特异性IgE(sIgE)、A值均值.结果进行组内和组间比较.结果:A组SIT总有效率90%(47/52),B组78%(39/50),前者明显高于后者(P<0.05);A组仅3例轻度副反应,B组有13例(26%)出现副反应;A组及B组SIT后ID风团直径、sIgE,A值均值都较SIT前明显下降(P<0.01);A组SIT后上述指标下降程度较B组更明显(P<0.05).结论:PPA及CPA的SIT疗效均较满意,但用PPA进行SIT的安全性和疗效更好. AIM: To study the effect of specific immunotherapy (SIT) with purified pollen allergens (caraway, humulus and chenopodium) on asthmatic patients. METHODS: The pollen allergens were purified by gelatin filtration. One hundred and two patients with seasonal asthma allergic to caraway, humulus or chenopodium pollen were divided randomly into 2 groups : observation group ( group A) and control group ( group B) and the 2 groups were given purified pollen allergens (PPA) and crude pollen allergens (CPA) respectively before the allergic season. The course was 3 months. The laboratory observation included the wheals' diameter of ID, specific IgE (sIgE) and mean A value before and after SIT. RESULTS: The general effective rate of SIT with purified allergens in group A was 90% (47/52) and that with crude allergens in group B was 78% (39/50). The former was significantly higher than the latter (P 〈 0. 05 ). Only 3 patients in group A had slight side-effects after SIT and 13 patients (26%) in group B had side-effects. A significant decrease in the diameter of skin wheal and slgE ( P 〈 0. 01 ) was observed after SIT in both groups and the decrease was more sig nificant in group A than in group B ( P 〈 0.05 ). CONCLUSION: The effective rates of SIT with both PPA and CPA are satisfactory. But SIT with PPA is more effective and safer than that with CPA.
出处 《第四军医大学学报》 CAS 北大核心 2006年第5期466-468,共3页 Journal of the Fourth Military Medical University
关键词 哮喘 纯化花粉变应原 免疫疗法 asthma purified pollen allergens immunotherapy
  • 相关文献

参考文献10

  • 1Campbell D,De Kruyff RH,Umetsu DT.Allergen immunotherapy:novel approaches in the management of allergic diseases and asthma[J].Clin Immunol,2000,97:193-202.
  • 2中华医学会呼吸病学分会哮喘学组.支气管哮喘防治指南(支气管哮喘的定义、诊断、治疗及教育和管理方案)[J].中华结核和呼吸杂志,2003,26(3):132-138. 被引量:3563
  • 3孙秀珍,刘昀,李雅莉,周玎.哮喘患者气传昆虫变应原疫苗的实验[J].第四军医大学学报,2004,25(19):1813-1815. 被引量:5
  • 4Rudolf V,Dietrich K.From allergen structure to new forms of allergen-specific immunotherapy[J].Current Opin Immunol,2002,14:718-727.
  • 5孙秀珍,李雅莉.花粉变应原研究概况[J].中国公共卫生,2002,18(2):245-246. 被引量:12
  • 6陈萍.哮喘免疫治疗研讨会纪要[J].中华结核和呼吸杂志,2000,23(10):586-587. 被引量:7
  • 7Rober NR,Harod SN,Ira F.Effectiveness of specific immunotherapy in the treatment of asthma[J].Chin Ther,2000,2:329-341.
  • 8Martin C,Alisa R.Recombinant allergen for diagnosis and therapy of allergic disease[J].J Allergy Clin Immunol,2000,6(3):409-418.
  • 9WHO Position Paper.Allergen immunotherapy:the therapeutic vaccines for allergic diseases[J].Eur J Allergy Clin Immunol Allergy,1998,53(Suppl44):1.
  • 10Cantani A,Arcese G,Lucenti P,et al.A three-year prospective study of specific immunotherapy to inhalant allergens:evidence of safety and efficacy in 300 children with allergic asthma[J].J Invest Allergol Clin Immunol,1997,7(2):90-97.

二级参考文献5

共引文献3580

同被引文献58

引证文献2

二级引证文献49

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部